Evolent Health (EVH) Tops Q4 EPS by 3c
Tweet
Share
E-mailGet Alerts EVH Hot Sheet
Join SI Premium – FREE
Evolent Health (NYSE: EVH) reported Q4 EPS of $0.08, $0.03 better than the analyst estimate of $0.05. Revenue for the quarter came in at $468.72 million versus the consensus estimate of $469.09 million.
For earnings history and earnings-related data on Evolent Health (EVH) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Barclays Starts DKSH Holding AG (DKSH:SW) at Overweight
- Barclays Upgrades Telia Co AB (TELIA:SS) (TLSNF) to Equalweight
- JPMorgan Starts BSE Limited (BSE:IN) at Neutral
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
